← Browse by Condition
Medical Condition
human immunodeficiency virus
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 4, Phase 2, Phase 1
ClinicalMetric tracks all active clinical trials for human immunodeficiency virus sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.
Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.
Frequently Asked Questions — human immunodeficiency virus Clinical Trials
How many clinical trials are currently recruiting for human immunodeficiency virus?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for human immunodeficiency virus, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for human immunodeficiency virus?
human immunodeficiency virus research spans Phase 1 (2 trials), Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a human immunodeficiency virus clinical trial?
Eligibility criteria for human immunodeficiency virus trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 1 2
Phase 2 1
Phase 4 1
Top Sponsors
1 trial
1 trial
1 trial
1 trial
1 trial
Recruiting Clinical Trials
NCT05266898 Phase 4
Recruiting
Enrollment
250 pts
Location
United States
Sponsor
Louisiana State University Hea...
NCT03300830
Recruiting
Enrollment
280 pts
Location
United States
Sponsor
National Cancer Institute (NCI...
NCT05159466
Recruiting
Enrollment
30 pts
Location
United States
Sponsor
Tulane University
NCT02479698 Phase 2
Recruiting
Enrollment
100 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05642858
Recruiting
Enrollment
260 pts
Location
United States
Sponsor
University of California, San ...
NCT07530198 Phase 1
Recruiting
Enrollment
22 pts
Location
Hong Kong
Sponsor
Immuno Cure Holding (HK) Limit...
NCT06205056 Phase 1
Recruiting
Enrollment
78 pts
Location
Uganda
Sponsor
U.S. Army Medical Research and...
Related Conditions
papillomavirus vaccines (1) papillomavirus infection (1) serology (1) cervical intraepithelial neoplasia (1) anal intraepithelial neoplasia (1) oral cavity infection (1) castleman s disease (1) kaposi s sarcoma (1) viral associated cancer (1) end stage renal disease (1) acquired immunodeficiency syndrome (1) bk virus infection (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology